The Decentralised procedure used for the registration of ROVIs biosimilar of enoxaparin has been completed with positive outcome.


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. (www.rovi.es) today announced topline results from the pivotal study PRISMA-3, a multicenter,...
4 min
19/03/2019